Insider Shareholders with Direct Ownership of Allogene Therapeutics, Inc. (ALLO)
This section provides a comprehensive overview of the insiders with direct ownership of Allogene Therapeutics, Inc. (ALLO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Allogene Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pfizer Inc
> 10% Shareholder |
22,032,040 | 0 | 22,032,040 $35.3 Million | 1 |
Oct 15, 2018
Added 0.25%
|
|
David D Chang
President and CEO |
3,247,128 | 165,897 | 5,317,237 $8.51 Million | 11 |
Feb 03, 2025
Reduced 0.86%
|
|
Arie Belldegrun
Director |
2,297,607 | 0 | 2,236,816 $3.58 Million | 5 |
Jan 24, 2025
Added 14.19%
|
|
Geoffrey M. Parker
CHIEF FINANCIAL OFFICER |
1,338,331 | 40,765 | 1,301,540 $2.08 Million | 7 |
Feb 03, 2025
Reduced 0.33%
|
|
Eric Thomas Schmidt
Chief Financial Officer |
835,215 | 55,401 | 862,439 $1.38 Million | 7 |
Mar 22, 2023
Added 39.29%
|
|
Alison Moore
Chief Technical Officer |
688,752 | 147,625 | 672,731 $1.08 Million | 15 |
Mar 22, 2023
Added 45.34%
|
|
Zachary Roberts
EVP of R&D |
713,856 | 70,721 | 643,135 $1.03 Million | 7 |
Feb 03, 2025
Reduced 2.84%
|
|
Earl Martin Douglas
SVP, General Counsel |
622,562 | 34,714 | 587,848 $940,556 | 5 |
Feb 03, 2025
Reduced 1.08%
|
|
Veer Bhavnagri
General Counsel |
334,140 | 135,702 | 556,049 $889,678 | 28 |
Mar 14, 2023
Reduced 4.08%
|
|
Rafael Amado
EVP of R&D |
481,878 | 80,696 | 541,946 $867,113 | 15 |
Oct 07, 2022
Reduced 1.54%
|
|
Franz B Humer
Director |
196,712 | 20,421 | 307,507 $492,011 | 6 |
Dec 05, 2024
Reduced 2.91%
|
| 488,294 | 912,618 | 303,063 $484,900 | 6 |
Jun 15, 2022
Added 12.72%
|
|
| 96,650 | 64,969 | 292,832 $468,531 | 8 |
Jun 13, 2023
Added 20.29%
|
|
|
Timothy L. Moore
Chief Technical Officer |
282,819 | 32,106 | 250,713 $401,140 | 4 |
Feb 03, 2025
Reduced 5.55%
|
| 162,575 | 0 | 162,575 $260,120 | 4 |
Jun 05, 2024
Added 27.44%
|
|
|
Deborah M. Messemer
Director |
197,511 | 46,417 | 157,629 $252,206 | 5 |
Dec 09, 2024
Reduced 5.48%
|
|
Lillian Smith
VP, Corporate Counsel |
56,545 | 0 | 140,390 $224,624 | 1 |
Apr 01, 2023
Added 28.71%
|
|
Annie Yoshiyama
SVP, Finance |
36,232 | 0 | 137,990 $220,784 | 1 |
Jan 24, 2025
Added 20.8%
|
|
Yinlin Jack Chen
SVP, Finance |
11,401 | 0 | 88,881 $142,209 | 1 |
Aug 10, 2023
Added 11.37%
|
| 35,328 | 10,000 | 25,328 $40,524 | 2 |
Aug 07, 2023
Reduced 28.31%
|
|
|
Pf Equity Holdings 2 B.V.
> 10% Shareholder |
0 | 22,032,040 | 0 $0 | 1 |
Mar 31, 2022
Reduced 100.0%
|